News

Informējam, ka pašlaik, 25.01.2023., EMVS darbībā novērojama traucējumi ar nereģistrēto produktu verifikāciju (IMT transakcijas).

Summarizing what was done in 2022 and outlining the plans for 2023, the European Medicines Verification Organisation (EMVO) in cooperation with the National Medicines Verification Organisations has published the EMVS Community Newsletter – 2022 Holiday Bulletin edition. In this bulletin, Inese Erdmane, Chairwoman of the Board at the Latvian Medicines Verification Organisation (LZVO), also talks about this year's achievements.

On November 30, 2022, a General Assembly meeting of stakeholders of the Latvian Medicines Verification Organisation (LZVO) was held, where the strategy and budget for 2023 were approved.

Apkopojot gala lietotāju radīto trauksmes brīdinājumu biežākos cēloņus, Latvijas Zāļu verifikācijas organizācija (LZVO) ir konstatējusi, ka gala lietotāji bieži rada trauksmes brīdinājumus, mēģinot atkārtoti verificēt atvērtu un dalītu iepakojumu.

The European Medicines Verification Organization (EMVO) has launched a Newsletter, which introduces to the criteria that allow the identification of the "critical countries" of the system, tells about Romania's verification experience and other current issues of the system.

In the nine months of this year, 20.5 million medicine packages were checked against falsification from the medicines purchased by citizens in pharmacies or used by patients in healthcare institutions. This is 8% more than in the same period of last year, according to data from the Latvian Medicines Verification Organization (LZVO).